Challenging Regimen for Long-Term Conservative Treatment of Endometrial Adenocarcinoma in Young Women: A Case Report and Review of the Literature

A 20-year-old obese Thai woman with polycystic ovary syndrome and clinical stage I well-differentiated endometrial carcinoma denied surgical staging. Chest X-ray and magnetic resonance imaging of the whole abdomen suggested neither distance metastasis nor local invasion of the cancer. After 3 months...

Full description

Bibliographic Details
Main Authors: Prasong Tanmahasamut, Thanyarat Wongwananuruk
Format: Article
Language:English
Published: Karger Publishers 2010-10-01
Series:Case Reports in Oncology
Subjects:
Online Access:http://www.karger.com/Article/FullText/321731
id doaj-5fda755fac7b4301907ad1b2c0c7df9e
record_format Article
spelling doaj-5fda755fac7b4301907ad1b2c0c7df9e2020-11-25T01:11:05ZengKarger PublishersCase Reports in Oncology1662-65752010-10-013338038510.1159/000321731321731Challenging Regimen for Long-Term Conservative Treatment of Endometrial Adenocarcinoma in Young Women: A Case Report and Review of the LiteraturePrasong TanmahasamutThanyarat WongwananurukA 20-year-old obese Thai woman with polycystic ovary syndrome and clinical stage I well-differentiated endometrial carcinoma denied surgical staging. Chest X-ray and magnetic resonance imaging of the whole abdomen suggested neither distance metastasis nor local invasion of the cancer. After 3 months of systemic progestin therapy with megestrol acetate (MA) 480 mg/day, the endometrial carcinoma persisted. The treatment was changed to a combination of levonorgestrel intrauterine system (LNG-IUS) and MA with a stepping-up from 160 to 480 mg/day. Complete remission was achieved at treatment month 9. Prevention of recurrence was provided using LNG-IUS plus MA 160 mg/day. Endometrial surveillance using trimonthly transvaginal ultrasonography and endometrial biopsy suggested no recurrence for at least 24 months after remission.http://www.karger.com/Article/FullText/321731Endometrial adenocarcinomaPolycystic ovary syndromeLevonorgestrel intrauterine system
collection DOAJ
language English
format Article
sources DOAJ
author Prasong Tanmahasamut
Thanyarat Wongwananuruk
spellingShingle Prasong Tanmahasamut
Thanyarat Wongwananuruk
Challenging Regimen for Long-Term Conservative Treatment of Endometrial Adenocarcinoma in Young Women: A Case Report and Review of the Literature
Case Reports in Oncology
Endometrial adenocarcinoma
Polycystic ovary syndrome
Levonorgestrel intrauterine system
author_facet Prasong Tanmahasamut
Thanyarat Wongwananuruk
author_sort Prasong Tanmahasamut
title Challenging Regimen for Long-Term Conservative Treatment of Endometrial Adenocarcinoma in Young Women: A Case Report and Review of the Literature
title_short Challenging Regimen for Long-Term Conservative Treatment of Endometrial Adenocarcinoma in Young Women: A Case Report and Review of the Literature
title_full Challenging Regimen for Long-Term Conservative Treatment of Endometrial Adenocarcinoma in Young Women: A Case Report and Review of the Literature
title_fullStr Challenging Regimen for Long-Term Conservative Treatment of Endometrial Adenocarcinoma in Young Women: A Case Report and Review of the Literature
title_full_unstemmed Challenging Regimen for Long-Term Conservative Treatment of Endometrial Adenocarcinoma in Young Women: A Case Report and Review of the Literature
title_sort challenging regimen for long-term conservative treatment of endometrial adenocarcinoma in young women: a case report and review of the literature
publisher Karger Publishers
series Case Reports in Oncology
issn 1662-6575
publishDate 2010-10-01
description A 20-year-old obese Thai woman with polycystic ovary syndrome and clinical stage I well-differentiated endometrial carcinoma denied surgical staging. Chest X-ray and magnetic resonance imaging of the whole abdomen suggested neither distance metastasis nor local invasion of the cancer. After 3 months of systemic progestin therapy with megestrol acetate (MA) 480 mg/day, the endometrial carcinoma persisted. The treatment was changed to a combination of levonorgestrel intrauterine system (LNG-IUS) and MA with a stepping-up from 160 to 480 mg/day. Complete remission was achieved at treatment month 9. Prevention of recurrence was provided using LNG-IUS plus MA 160 mg/day. Endometrial surveillance using trimonthly transvaginal ultrasonography and endometrial biopsy suggested no recurrence for at least 24 months after remission.
topic Endometrial adenocarcinoma
Polycystic ovary syndrome
Levonorgestrel intrauterine system
url http://www.karger.com/Article/FullText/321731
work_keys_str_mv AT prasongtanmahasamut challengingregimenforlongtermconservativetreatmentofendometrialadenocarcinomainyoungwomenacasereportandreviewoftheliterature
AT thanyaratwongwananuruk challengingregimenforlongtermconservativetreatmentofendometrialadenocarcinomainyoungwomenacasereportandreviewoftheliterature
_version_ 1725172796080783360